CVS Health Corporation (CVS)
NYSE: CVS
· Real-Time Price · USD
79.67
1.23 (1.57%)
At close: Oct 14, 2025, 3:59 PM
79.64
-0.04%
Pre-market: Oct 15, 2025, 07:29 AM EDT
1.57% (1D)
| Bid | 79.64 |
| Market Cap | 101.05B |
| Revenue (ttm) | 386.64B |
| Net Income (ttm) | 4.53B |
| EPS (ttm) | 3.59 |
| PE Ratio (ttm) | 22.19 |
| Forward PE | 10.97 |
| Analyst | Buy |
| Dividends | $2.66 |
| Ask | 79.94 |
| Volume | 7,812,620 |
| Avg. Volume (20D) | 7,631,954 |
| Open | 78.31 |
| Previous Close | 78.44 |
| Day's Range | 77.80 - 79.94 |
| 52-Week Range | 43.56 - 79.94 |
| Beta | 0.61 |
| Ex-Dividend Date | Oct 23, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for CVS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCVS Health Corporation is scheduled to release its earnings on
Oct 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+2.12%
CVS Health Corporation shares are trading higher a...
Unlock content with
Pro Subscription
1 month ago
+2.29%
CVS shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $67 to $79.
10 hours ago · proactiveinvestors.co.uk
CVS in focus as CMA proposes price caps and more transparency on chargesVet chain CVS Group (AIM:CVSG) will be in focus oin Wednesday after the Competition and Markets Authority proposed a package of 21 measures aimed at overhauling the market to improve transparency, con...
